← Back
$ALXO All transactions

ALX ONCOLOGY HOLDINGS INC

▲ BUY
10 / 10

Conviction

$ Value

$5.0M

Shares

3,184,713

Price

$2

Filed

Feb 4

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

GOODMAN COREY S

Title

CIK

0001278411

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-02-02

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

8,453,038

Footnotes

The shares are held of record by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. The reporting person, a director of venBio Global Strategic GP II, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. The reporting person, a director of venBio Global Strategic GP, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by venBio SPV, LLC, which is wholly-owned by venBio Global Strategic Fund, L.P. The reporting person, a managing director of venBio SPV, LLC, disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by the Goodman Barinaga Trust for which the reporting person serves as trustee. | The shares are held of record by Emaldi Corporation for which the reporting person serves as a director. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.

Filing Info

Accession No.

0001278411-26-000002

Form Type

4

Issuer CIK

0001810182

GOODMAN COREY S's History

Date Ticker Type Value
2026-02-02 ALXO $5.0M
2026-01-20 ALXO A $0

Other Insiders at ALXO (90d)

Insider Bought Sold Last
Klencke Barbara
Chief Medical Officer
2026-04-16
Lettmann Jason
CHIEF EXECUTIVE OFFICER
2026-01-26
Pinto Shelly
SVP, FINANCE AND CAO
2026-01-26
Knight Jeff E.
Chief Dev & Operating Officer
2026-04-16
Shantharam Harish
Chief Financial Officer
2026-01-26